🇺🇸 FDA
Patent

US 8426385

Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and preparation method thereof

granted A61KA61K31/337A61K47/6951

Quick answer

US patent 8426385 (Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and preparation method thereof) held by Hainan Hdeton Science and Technology Co., Ltd. expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Hainan Hdeton Science and Technology Co., Ltd.
Grant date
Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/337, A61K47/6951, A61P, A61P35/00